116 related articles for article (PubMed ID: 35050429)
1. Identification of miR-4510 as a metastasis suppressor of gastric cancer through regulation of tumor microenvironment via targeting GPC3.
Ma HF; Shu P; Shi XH; Wang M; Jiang MF
Clin Exp Metastasis; 2022 Apr; 39(2):363-374. PubMed ID: 35050429
[TBL] [Abstract][Full Text] [Related]
2. New tumor suppressor microRNAs target glypican-3 in human liver cancer.
Cartier F; Indersie E; Lesjean S; Charpentier J; Hooks KB; Ghousein A; Desplat A; Dugot-Senant N; Trézéguet V; Sagliocco F; Hagedorn M; Grosset CF
Oncotarget; 2017 Jun; 8(25):41211-41226. PubMed ID: 28476031
[TBL] [Abstract][Full Text] [Related]
3. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
4. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract][Full Text] [Related]
5. Targeting GPC3
Li D; Wang Y; Shi C; Fu S; Sun YF; Li C
Ann Med; 2023 Dec; 55(1):2189295. PubMed ID: 37036308
[TBL] [Abstract][Full Text] [Related]
6. The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.
Wang H; Dong X; Gu X; Qin R; Jia H; Gao J
PLoS One; 2015; 10(6):e0125474. PubMed ID: 26098560
[TBL] [Abstract][Full Text] [Related]
7. Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.
Han S; Ma X; Zhao Y; Zhao H; Batista A; Zhou S; Zhou X; Yang Y; Wang T; Bi J; Xia Z; Bai Z; Garkavtsev I; Zhang Z
Oncotarget; 2016 Jul; 7(28):44406-44416. PubMed ID: 27259271
[TBL] [Abstract][Full Text] [Related]
8. MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3.
Huang N; Lin J; Ruan J; Su N; Qing R; Liu F; He B; Lv C; Zheng D; Luo R
FEBS Lett; 2012 Mar; 586(6):884-91. PubMed ID: 22449976
[TBL] [Abstract][Full Text] [Related]
9. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas.
Ushiku T; Uozaki H; Shinozaki A; Ota S; Matsuzaka K; Nomura S; Kaminishi M; Aburatani H; Kodama T; Fukayama M
Cancer Sci; 2009 Apr; 100(4):626-32. PubMed ID: 19243386
[TBL] [Abstract][Full Text] [Related]
10. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
12. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
[TBL] [Abstract][Full Text] [Related]
13. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.
Wang YL; Zhu ZJ; Teng DH; Yao Z; Gao W; Shen ZY
World J Gastroenterol; 2012 May; 18(19):2408-14. PubMed ID: 22654434
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1291-mediated silencing of IRE1α enhances Glypican-3 expression.
Maurel M; Dejeans N; Taouji S; Chevet E; Grosset CF
RNA; 2013 Jun; 19(6):778-88. PubMed ID: 23598528
[TBL] [Abstract][Full Text] [Related]
16. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
17. miR-618 Suppresses Metastasis in Gastric Cancer by Downregulating the Expression of TGF-β2.
Shi J; Gong L; Chen L; Luo J; Song G; Xu J; Lv Z; Tao H; Xia Y; Ye Z
Anat Rec (Hoboken); 2019 Jun; 302(6):931-940. PubMed ID: 30737902
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
19. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
[TBL] [Abstract][Full Text] [Related]
20. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
